Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Amlodipine Besylate; Olmesartan Medoxomil Patent Expiration

Amlodipine Besylate; Olmesartan Medoxomil is Used for managing high blood pressure. It was first introduced by Cosette Pharmaceuticals Inc in its drug Azor on Sep 26, 2007. 15 different companies have introduced drugs containing Amlodipine Besylate; Olmesartan Medoxomil.


Amlodipine Besylate; Olmesartan Medoxomil Patents

Given below is the list of patents protecting Amlodipine Besylate; Olmesartan Medoxomil, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Azor US5616599

(Pediatric)

 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use Oct 25, 2016

(Expired)

 Cosette
Azor US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use Apr 25, 2016

(Expired)

 Cosette



Amlodipine Besylate; Olmesartan Medoxomil's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amlodipine Besylate; Olmesartan Medoxomil Generic API Manufacturers

Several generic applications have been filed for Amlodipine Besylate; Olmesartan Medoxomil. The first generic version for Amlodipine Besylate; Olmesartan Medoxomil was by Teva Pharmaceuticals Usa and was approved on Oct 26, 2016. And the latest generic version is by Hetero Labs Ltd Unit V and was approved on Feb 14, 2025.

Given below is the list of companies who have filed for Amlodipine Besylate; Olmesartan Medoxomil generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE INC

Accord Healthcare Inc Usa has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Accord Hlthcare Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE; 40MG

tablet Discontinued ORAL N/A Aug 30, 2018
EQ 5MG BASE; 40MG

tablet Discontinued ORAL N/A Aug 30, 2018
EQ 10MG BASE; 20MG

tablet Discontinued ORAL N/A Aug 30, 2018
EQ 5MG BASE; 20MG

tablet Discontinued ORAL N/A Aug 30, 2018





2. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Oct 28, 2016
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Oct 28, 2016
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Oct 28, 2016
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Oct 28, 2016


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Jul 17, 2017
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Jul 17, 2017
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Jul 17, 2017
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Jul 17, 2017


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Vadodara Alembic Pharmaceuticals Ltd
Panelav Alembic Pharmaceuticals Limited
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)
Vadodara Alembic Pharmaceuticals, Ltd
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited





4. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Aug 14, 2017
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Aug 14, 2017
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Aug 14, 2017
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Aug 14, 2017





5. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB May 15, 2017
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB May 15, 2017
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB May 15, 2017
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB May 15, 2017


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd
Bachupally Aurobindo Pharma Limited
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Sangareddy Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





6. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Discontinued ORAL N/A Jul 5, 2017
EQ 5MG BASE; 40MG

tablet Discontinued ORAL N/A Jul 5, 2017
EQ 10MG BASE; 20MG

tablet Discontinued ORAL N/A Jul 5, 2017
EQ 10MG BASE; 40MG

tablet Discontinued ORAL N/A Jul 5, 2017





7. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Feb 14, 2025
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Feb 14, 2025
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Feb 14, 2025
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Feb 14, 2025





8. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Discontinued ORAL N/A May 15, 2017
EQ 10MG BASE; 20MG

tablet Discontinued ORAL N/A May 15, 2017
EQ 10MG BASE; 40MG

tablet Discontinued ORAL N/A May 15, 2017
EQ 5MG BASE; 40MG

tablet Discontinued ORAL N/A May 15, 2017


Manufacturing Plant Locations
New

Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.

Country City Firm Name
India
Roorkee Jubilant Generics Limited





9. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Oct 26, 2016
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Oct 26, 2016
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Oct 26, 2016
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Oct 26, 2016





10. MICRO LABS

Micro Labs Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Micro Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Nov 2, 2017
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Nov 2, 2017
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Nov 2, 2017
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Nov 2, 2017


Manufacturing Plant Locations
New

Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.

Country City Firm Name
India
Verna Micro Labs Limited
Bangalore Micro Labs Limited
Bengaluru Micro Labs Limited
Bengaluru Micro Labs Limited, Central Analytical Laboratory





11. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Dec 3, 2018
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Dec 3, 2018
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Dec 3, 2018
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Dec 3, 2018





12. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 10MG BASE; 40MG

tablet Discontinued ORAL N/A Oct 26, 2016
EQ 5MG BASE; 20MG

tablet Discontinued ORAL N/A Oct 26, 2016
EQ 5MG BASE; 40MG

tablet Discontinued ORAL N/A Oct 26, 2016
EQ 10MG BASE; 20MG

tablet Discontinued ORAL N/A Oct 26, 2016





13. TORRENT

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 20MG

tablet Discontinued ORAL N/A Nov 25, 2016
EQ 10MG BASE; 40MG

tablet Discontinued ORAL N/A Nov 25, 2016
EQ 10MG BASE; 20MG

tablet Discontinued ORAL N/A Nov 25, 2016
EQ 5MG BASE; 40MG

tablet Discontinued ORAL N/A Nov 25, 2016


Manufacturing Plant Locations
New

Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.

Country City Firm Name
India
Gandhi Nagar Torrent Pharmaceuticals Limited
Bharuch Torrent Pharmaceuticals Limited
Pithampur Torrent Pharmaceuticals Limited
Thanam Torrent Pharmaceuticals Limited
Indrad Torrent Pharmaceuticals Limited
United States
Kalamazoo Torrent Pharma Inc.
Basking Ridge Torrent Pharma Inc.





14. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Amlodipine Besylate; Olmesartan Medoxomil. All of these versions come by the name AMLODIPINE AND OLMESARTAN MEDOXOMIL. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 5MG BASE; 40MG

tablet Prescription ORAL AB Sep 22, 2017
EQ 5MG BASE; 20MG

tablet Prescription ORAL AB Sep 22, 2017
EQ 10MG BASE; 20MG

tablet Prescription ORAL AB Sep 22, 2017
EQ 10MG BASE; 40MG

tablet Prescription ORAL AB Sep 22, 2017